RETA
Reata Pharmaceuticals Inc
SVP and Chief Accounting Officer Bhaskar Anand sold $93K of Reata Pharmaceuticals Inc
Sold$92,714
$85.37Price
1,086Shares
−4%Stake
What RETA did after the filing
- The stock from Wed, May 17 close, $82.04
- +24.3%
- S&P 500, same days
- +7.2%
Measured over 30 trading days, to the Jun 30 close.
Traded Mon, May 15. Filed Wed, May 17, 12:26 PM ET, during the session. Returns use the May 17 close and the Jun 30 close. Not investment advice.